Anna Pagonakis

Array ( [id] => 4765734 [patent_doc_number] => 20080176946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'FORMULATIONS FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/015403 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27840 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176946.pdf [firstpage_image] =>[orig_patent_app_number] => 12015403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943557 [patent_doc_number] => 20110104177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'HISTONE DEACETYLASE INHIBITORS, COMBINATION THERAPIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/521569 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34346 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104177.pdf [firstpage_image] =>[orig_patent_app_number] => 12521569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808205 [patent_doc_number] => 20080171783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE' [patent_app_type] => utility [patent_app_number] => 11/966666 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 90698 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171783.pdf [firstpage_image] =>[orig_patent_app_number] => 11966666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353636 [patent_doc_number] => 20100086586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 12/520409 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3018 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086586.pdf [firstpage_image] =>[orig_patent_app_number] => 12520409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317477 [patent_doc_number] => 08232253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Treatment of lung cancer' [patent_app_type] => utility [patent_app_number] => 12/519578 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 24 [patent_no_of_words] => 9627 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591910 [patent_doc_number] => 20100130539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'IMIDAZOPYRIDINE INHIBITORS OF IAP' [patent_app_type] => utility [patent_app_number] => 12/520205 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17418 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130539.pdf [firstpage_image] =>[orig_patent_app_number] => 12520205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867475 [patent_doc_number] => 20080146534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 11/956488 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1702 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146534.pdf [firstpage_image] =>[orig_patent_app_number] => 11956488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880498 [patent_doc_number] => 20080153881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'ALPHA-2B RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/954530 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4079 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153881.pdf [firstpage_image] =>[orig_patent_app_number] => 11954530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619450 [patent_doc_number] => 20100324130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'DAA PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR CANCER IMAGING AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/518067 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8760 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324130.pdf [firstpage_image] =>[orig_patent_app_number] => 12518067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617206 [patent_doc_number] => 20100099757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'DISULFIRAM DOSES AND TREATMENT REGIMEN SUITABLE FOR TREATMENT OF ANGIOGENESIS-DEPENDENT DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/517266 [patent_app_country] => US [patent_app_date] => 2007-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6410 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099757.pdf [firstpage_image] =>[orig_patent_app_number] => 12517266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728100 [patent_doc_number] => 20080207644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Therapeutic materials and methods' [patent_app_type] => utility [patent_app_number] => 11/986878 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10544 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207644.pdf [firstpage_image] =>[orig_patent_app_number] => 11986878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445963 [patent_doc_number] => 20100144741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'ETHANOLAMINE DERIVATIVES USEFUL AS BACE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/515521 [patent_app_country] => US [patent_app_date] => 2007-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16744 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144741.pdf [firstpage_image] =>[orig_patent_app_number] => 12515521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430627 [patent_doc_number] => 20100143332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'COMBINATION THERAPY FOR PROLIFERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/514758 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20564 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143332.pdf [firstpage_image] =>[orig_patent_app_number] => 12514758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899849 [patent_doc_number] => 20080119463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => '4-Anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (AML)' [patent_app_type] => utility [patent_app_number] => 11/985100 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2685 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119463.pdf [firstpage_image] =>[orig_patent_app_number] => 11985100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904532 [patent_doc_number] => 20080113946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => utility [patent_app_number] => 11/984179 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17792 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113946.pdf [firstpage_image] =>[orig_patent_app_number] => 11984179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713294 [patent_doc_number] => 08399434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method of activation of oxazaphosphorines' [patent_app_type] => utility [patent_app_number] => 12/375482 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7833 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12375482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713294 [patent_doc_number] => 08399434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method of activation of oxazaphosphorines' [patent_app_type] => utility [patent_app_number] => 12/375482 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7833 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12375482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442604 [patent_doc_number] => 20100104661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'DISCONTINUOUS METHODS OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/446938 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13857 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104661.pdf [firstpage_image] =>[orig_patent_app_number] => 12446938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11793162 [patent_doc_number] => 09402852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Method to enhance tissue regeneration' [patent_app_type] => utility [patent_app_number] => 12/445986 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 28 [patent_no_of_words] => 13047 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12445986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675646 [patent_doc_number] => 20080213275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'USE OF MTKI 1 FOR TREATING OR PREVENTING BONE CANCER' [patent_app_type] => utility [patent_app_number] => 11/875429 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6160 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213275.pdf [firstpage_image] =>[orig_patent_app_number] => 11875429 [rel_patent_id] =>[rel_patent_doc_number] =>)